Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

334
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
334
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

776
Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
776
Endocarditis II: Clinical Features of Infective Endocarditis01:25

Endocarditis II: Clinical Features of Infective Endocarditis

801
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
801
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

578
Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
578
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

324
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
324

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Platelet activation and bacterial interactions: linking immunothrombosis to infectious pathophysiology.

Journal of thrombosis and haemostasis : JTH·2026
Same author

The impact of thrombocytopenia on mortality in infective endocarditis - a <i>meta</i>-analysis.

International journal of cardiology. Heart & vasculature·2025
Same author

Assessment of a next generation sequencing gene panel strategy in 133 patients with negative thrombophilia screening.

Journal of thrombosis and haemostasis : JTH·2024
Same author

Comparison between Duke, European Society of Cardiology 2015, International Society for Cardiovascular Infectious Diseases 2023, and European Society of Cardiology 2023 criteria for the diagnosis of transcatheter aortic valve replacement-related infective endocarditis.

European heart journal. Cardiovascular Imaging·2024
Same author

Should We Give Antithrombotic Therapy to Patients With Infective Endocarditis?: A Serious Question, But Unresolved.

JACC. Advances·2024
Same author

Molecular Mimicry of the Viral Spike in the SARS-CoV-2 Vaccine Possibly Triggers Transient Dysregulation of ACE2, Leading to Vascular and Coagulation Dysfunction Similar to SARS-CoV-2 Infection.

Viruses·2023

Related Experiment Video

Updated: Apr 4, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

The Potential Role of Statins in Infective Endocarditis: A Meta-Analysis.

Nadji Hannachi1, Antoine Mariotti2,3,4, Laurence Camoin-Jau2,3,4

  • 1Département de Pharmacie, Faculté de Médecine, Université Ferhat Abbas Sétif I, Sétif 19000, Algérie.

Current Vascular Pharmacology
|April 2, 2026
PubMed
Summary

Statin use was associated with a lower incidence of infective endocarditis (IE) and reduced embolic events (EE) and mortality in a meta-analysis. These findings suggest statins may offer protective benefits against IE and its complications.

Keywords:
Statinsembolic eventsinfective endocarditismeta-analysismortality.prevention

More Related Videos

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

18.1K
An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

7.4K

Related Experiment Videos

Last Updated: Apr 4, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K
Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat

Published on: June 4, 2012

18.1K
An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
07:50

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues

Published on: January 7, 2019

7.4K

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Statins possess pleiotropic effects with potential benefits in infectious diseases.
  • The role of statins in infective endocarditis (IE) is not well-established.
  • Research is needed to clarify statin impact on IE frequency and outcomes.

Purpose of the Study:

  • To evaluate the impact of statin use on IE frequency.
  • To assess the effect of statins on embolic events (EE) and mortality in IE patients.

Main Methods:

  • A meta-analysis of eleven observational studies (8 retrospective, 3 prospective) involving 35,844 patients.
  • Primary outcome: IE frequency in statin users vs. non-users.
  • Secondary outcomes: EE and follow-up mortality (6 months to 1 year).

Main Results:

  • Statin use was linked to a significantly lower IE frequency (OR: 0.52; P=0.003).
  • IE patients on statins experienced fewer EE (OR: 0.50; P=0.04).
  • Statin use significantly reduced follow-up mortality (HR: 0.70; P<0.00001).

Conclusions:

  • Statins' anti-inflammatory, endothelial-stabilizing, and antithrombotic properties may counteract IE mechanisms.
  • Statin use is associated with reduced IE incidence, fewer EE, and lower mortality.
  • Further research is warranted to confirm these protective benefits.